Alnylam Pharmaceuticals Newsroom

(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest

Alnylam Pharmaceuticals's (NYSE:ALNY) short percent of float has risen 4.82% since its last report. The company recently reported that it has 2.63 million shares sold short, which is 2.39% of all regu

BenzingaMay 17 15:30 ET

S&P 500 Futures Rise In Premarket Trading; GameStop, Deere Lag

This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Chubb Ltd. (CB) was up 8.0% in pre-market trading,

Dow JonesMay 16 07:31 ET

Most Attractive Short-term Overwriting Stocks for June Expiration - Goldman

Goldman Sachs analysts identified short-term overwriting opportunities in large-cap, high implied volatility stocks that do not have earnings events.

Seeking AlphaMay 15 10:43 ET

S&P 500 Futures Steady In Premarket Trading; Monday.Com, Nextracker Lead

This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, monday.com Ltd. (MNDY) was up 19.4% in pre-market t

Dow JonesMay 15 07:31 ET

Cantor Picks 14 Undervalued Biotech Stocks Worth a Second Look

Seeking AlphaMay 12 11:00 ET

10 Health Care Stocks With Whale Alerts In Today's Session

Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth.

BenzingaMay 9 13:35 ET

Alnylam Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Alnylam Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 7 07:14 ET

Express News | Alnylam Pharmaceuticals Inc : H.c. Wainwright Raises Target Price to $400 From $395

ReutersMay 7 06:18 ET

Alnylam Issues 2023 Corporate Responsibility Report

Alnylam Issues 2023 Corporate Responsibility ReportMay 07, 2024– Highlighted New Disclosures of Company's Impact on the Environment—Including Multiyear Data on Greenhouse Gas (GHG) Emissions, Energy,

Alnylam Pharmaceuticals, Inc.May 7 00:00 ET

The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Yahoo FinanceMay 5 08:48 ET

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 3 13:01 ET

Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y

Yahoo FinanceMay 3 12:29 ET

Alnylam Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceMay 3 09:21 ET

Alnylam Pharma (ALNY) Receives a Hold From Oppenheimer

TipRanksMay 3 08:11 ET

Express News | Chardan Capital Maintains Buy on Alnylam Pharmaceuticals, Maintains $225 Price Target

BenzingaMay 3 08:03 ET

RBC Capital Sticks to Their Buy Rating for Alnylam Pharma (ALNY)

TipRanksMay 3 06:43 ET

Express News | Alnylam Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $138 From $136

ReutersMay 3 05:25 ET

Alnylam Pharmaceuticals Inc (ALNY) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...

Yahoo FinanceMay 3 03:11 ET

Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight

Yahoo FinanceMay 3 01:06 ET

Strong Financial Growth and Promising Clinical Trials Bolster Buy Rating for Alnylam Pharmaceuticals

TipRanksMay 2 23:45 ET